- Report
- January 2026
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 190 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 196 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 194 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 188 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 181 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 184 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- November 2025
- 187 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 198 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP

Downstream Processing (DSP) is a biotechnology process used to purify and concentrate biopharmaceuticals, such as proteins, antibodies, and enzymes. It is a critical step in the production of biopharmaceuticals, as it ensures the quality and safety of the final product. DSP involves a series of steps, such as filtration, chromatography, and ultrafiltration, to separate and purify the desired product from the rest of the components. The process is highly complex and requires specialized equipment and expertise.
The DSP market is growing rapidly, driven by the increasing demand for biopharmaceuticals and the need for efficient and cost-effective production processes. The market is expected to continue to grow in the coming years, driven by technological advancements and the increasing demand for biopharmaceuticals.
Some of the major companies in the DSP market include Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Sartorius AG, and Pall Corporation. Show Less Read more